Does nebulised hypertonic (3%) saline reduce the duration of hospital admission in infants with bronchiolitis? - Nebulised hypertonic (3%) saline in the treatment of bronchiolitis

West Middlesex University Hospital0 个研究点目标入组 0 人开始时间: 2010年3月17日最近更新: 2020年10月13日

适应症

试验速览

暂无简介。

•Inclusion criteria - all infants under the age of 12 months with a clinical diagnosis of bronchiolitis
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Exclusion criteria - infants who are transferred out of West Middlesex Hospital whilst enrolled in the trial and those that have a change of diagnosis during their admission. For example, a number of infants with bronchiolitis end up receiving intravenous antibiotics for probably super-added bacterial lower respiratory tract infection. In these cases, the antibiotics may be a significant confounding factor to any findings and hence infants will no longer be eligible for inclusion, as commencing treatment with antibiotics suggests that viral bronchiolitis is not the primary diagnosis.
•However, data will be analysed regardless, as the quality of any evidence is superior if there is an intention to treat analysis.

发起方

West Middlesex University Hospital